CanSino Net Interest Income from 2010 to 2026
| CJH Stock | 3.54 0.01 0.28% |
Net Interest Income | First Reported 2010-12-31 | Previous Quarter 4.3 M | Current Value 4.1 M | Quarterly Volatility 16.6 M |
Check CanSino Biologics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CanSino Biologics' main balance sheet or income statement drivers, such as Tax Provision of 2.3 M, Net Interest Income of 4.1 M or Interest Income of 44.4 M, as well as many indicators such as . CanSino financial statements analysis is a perfect complement when working with CanSino Biologics Valuation or Volatility modules.
CanSino | Net Interest Income |
The evolution of Net Interest Income for CanSino Biologics provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how CanSino Biologics compares to historical norms and industry peers.
Latest CanSino Biologics' Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of CanSino Biologics over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. CanSino Biologics' Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CanSino Biologics' overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
CanSino Net Interest Income Regression Statistics
| Arithmetic Mean | 9,309,979 | |
| Geometric Mean | 1,205,408 | |
| Coefficient Of Variation | 178.09 | |
| Mean Deviation | 12,150,951 | |
| Median | 228,000 | |
| Standard Deviation | 16,580,201 | |
| Sample Variance | 274.9T | |
| Range | 58.8M | |
| R-Value | 0.42 | |
| Mean Square Error | 241.8T | |
| R-Squared | 0.18 | |
| Significance | 0.09 | |
| Slope | 1,375,473 | |
| Total Sum of Squares | 4398.4T |
CanSino Net Interest Income History
About CanSino Biologics Financial Statements
CanSino Biologics shareholders use historical fundamental indicators, such as Net Interest Income, to determine how well the company is positioned to perform in the future. Although CanSino Biologics investors may analyze each financial statement separately, they are all interrelated. The changes in CanSino Biologics' assets and liabilities, for example, are also reflected in the revenues and expenses on on CanSino Biologics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 4.3 M | 4.1 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for CanSino Stock Analysis
When running CanSino Biologics' price analysis, check to measure CanSino Biologics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CanSino Biologics is operating at the current time. Most of CanSino Biologics' value examination focuses on studying past and present price action to predict the probability of CanSino Biologics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CanSino Biologics' price. Additionally, you may evaluate how the addition of CanSino Biologics to your portfolios can decrease your overall portfolio volatility.